Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Mexico's top court demands regulation on medical marijuana after long delays

Published 08/14/2019, 10:42 PM
Updated 08/14/2019, 10:46 PM
Mexico's top court demands regulation on medical marijuana after long delays

MEXICO CITY (Reuters) - Mexico's supreme court ordered the health ministry on Wednesday to issue regulation within six months on medical marijuana use, saying its failure to do so after legalization in 2017 had put rights at risk for patients, including children.

The court made the decision as part of its ruling in favor of a child who needed medication derived from cannabis substance THC to treat epilepsy.

"Due to the absence of rules regulating the therapeutic use of cannabis, it was impossible for the plaintiff to access treatment based on this substance or any of its derivatives," the court said in a statement.

The health ministry had been instructed to update its guidelines within half a year following a June 2017 reform to legalize marijuana for medical and scientific needs.

The ministry said in a statement on Wednesday it would comply with the court's ruling and ensure the child's access to treatment.

President Andres Manuel Lopez Obrador's government submitted a bill in November to create a medical marijuana industry and allow its recreational use, part of a crime-fighting plan that would make Mexico one of the world's most populous countries to legalize the drug.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.